About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Epilepsy Clinical Trials in Los Angeles | 26 Studies

Clinical Trials EpilepsyLos Angeles

Epilepsy Clinical Trials in Los Angeles

Find 26 clinical trials for epilepsy near Los Angeles, California. Connect with research centers in your area.

All Epilepsy trials nationwide All trials in Los Angeles

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 26 trials

RecruitingA Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet SyndromeThis is a multicenter, Phase 3, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of clemizole hydrochloride (EPX-100) as adjunctive…NCT04462770·Birmingham, Alabama and 67 others

Epilepsy Trials in Other Cities

New York Chicago Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

Active not recruitingA Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE)This (DEEp OCEAN Study) is a double-blind, randomized, placebo-controlled, multicenter study to investigate the efficacy, safety, and tolerability of LP352 in the treatment of…NCT06719141·Little Rock, Arkansas and 115 others

CompletedA 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic SeizuresStudy A0081106 is a 12-month open-label study to evaluate the long term safety and tolerability of pregabalin as add-on therapy in pediatric subjects 1 month to 16 years of age…NCT01463306·Tucson, Arizona and 150 others

CompletedA Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic EncephalopathiesThe purpose of this study is to investigate the effect on the frequency of all seizures (convulsive and drop) in participants treated with TAK-935 compared to placebo.NCT03650452·Phoenix, Arizona and 43 others

Enrolling by invitationLong-term Safety and Tolerability of BHV-7000A study to determine if BHV- 7000 is safe and tolerable in adults with refractory focal onset epilepsyNCT06443463·Birmingham, Alabama and 282 others

CompletedA Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset SeizuresThis is a multicenter, double-blind, randomized, placebo-controlled dose response study, with an 8-week prospective baseline and an 18 week double-blind treatment period…NCT01866111·Phoenix, Arizona and 66 others

TerminatedBetaquik as an Adjunct to Dietary Management of Epilepsy in Adults on the Modified Atkins DietThe purpose of this pilot study is to measure adherence and quality of life in adults with intractable epilepsy following the Modified Atkins Diet (MAD) with Betaquik, a…NCT03790436·Los Angeles, California

Active not recruitingA Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset EpilepsyThe purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.NCT06132893·Phoenix, Arizona and 103 others

TerminatedA Study of Lorcaserin as Adjunctive Treatment in Participants With Dravet SyndromeThe primary purpose of the study is to demonstrate that lorcaserin has superior efficacy compared to placebo on percent change in frequency of convulsive seizures per 28 days in…NCT04572243·Birmingham, Alabama and 29 others

CompletedA Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset SeizuresThis study evaluated the efficacy and safety of two trough-ranges of everolimus given as adjunctive therapy in patients with tuberous sclerosis complex (TSC) who had refractory…NCT01713946·Birmingham, Alabama and 103 others

TerminatedNatural History Study of Infants and Children With Developmental and Epileptic EncephalopathiesThis is a multicenter, prospective, 2-year observational study in infants and children with developmental and epileptic encephalopathies (DEEs).NCT04537832·Los Angeles, California and 15 others

Active not recruitingA Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)This (DEEp SEA Study) is a double-blind, randomized, placebo-controlled, multicenter study to investigate the efficacy, safety, and tolerability of LP352 in the treatment of…NCT06660394·Little Rock, Arkansas and 104 others

CompletedPreventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis ComplexStudy design is a Phase IIb prospective multi-center, randomized, placebo-controlled, double-blind clinical trial.NCT02849457·Birmingham, Alabama and 12 others

CompletedPharmacokinetics of Understudied Drugs Administered to Children Per Standard of CareUnderstudied drugs will be administered to children per standard of care as prescribed by their treating caregiver and only biological sample collection during the time of drug…NCT01431326·Anchorage, Alaska and 51 others

CompletedA Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 YearsStudy A0081041 is a double blind, placebo controlled, randomized, parallel group, multicenter study to evaluate the safety and efficacy of two dose levels of pregabalin…NCT01389596·Tucson, Arizona and 85 others

CompletedClobazam in Subjects With Lennox-Gastaut SyndromeThe purpose of this study is to evaluate the safety and efficacy of clobazam as adjunctive therapy in the treatment of seizures which lead to drop attacks (drop seizures) in…NCT00162981·Phoenix, Arizona and 13 others

Enrolling by invitationA Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)This (DEEp OLE Study) is a multicentre, open-label study to investigate the long-term safety, efficacy, tolerability, and pharmacokinetics (PK) of LP352 in the treatment of…NCT06908226·Little Rock, Arkansas and 87 others

CompletedEfficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset SeizuresThis study is to evaluate the efficacy of YKP3089 in reducing seizure frequency when compared to baseline in subjects with partial onset seizures not fully controlled despite…NCT01397968·Phoenix, Arizona and 37 others

CompletedRetigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in EpilepsyThis Phase 3 study is being conducted to evaluate the efficacy and safety of retigabine dosed at 1200 mg/day, in three equally divided doses, compared with placebo in patients…NCT00232596·Birmingham, Alabama and 53 others

RecruitingStudy of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))This clinical trial is designed to test whether a single image-guided intracerebral administration of inhibitory nerve cells, called interneurons (NRTX-1001), into subjects with…NCT05135091·Birmingham, Alabama and 34 others

Page 1 of 2Next

Other Conditions in Los Angeles

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia